Brazil’s Biorigin to double Bioenhance production line in the US

The investment in the company’s Louisville, Kentucky unit will include the purchase of a new fermenter that will start operating in the first semester of 2019.

“The expansion project was elaborated with due care in order to reduce set-up in fermentation and to optimize the use of other industrial assets, therefore, increasing our production capacity of the Bioenhance line,” ​said César Martins, Biorigin’s Global Operations Manager.

According to the company, this is the third expansion since its foundation 15 years ago, totaling investments of around US$ 200 million.

“These expansion initiatives were stimulated by the positive perspectives of the market, as well as by the trends related to health and well-being, which lead to an increasing search for natural ingredients, clean label, Non GMO,” ​added Mario Steinmetz, Biorigin’s General Manager.